breastscape v1.0

breastscape v1.0 is an image processing software designed to enhance the analysis of breast MRI studies, particularly DCE-MRI, by providing tools for visualization, quantitative kinetic analysis, lesion segmentation, and BI-RADS reporting. Its methodology involves semi-automatic processing of MR images with user refinement capabilities and specific modules for diagnostic support (BreastApp) and MR-guided interventional planning (BreastLoc), aiming to improve efficiency and provide detailed information for clinical decision-making.

breastscape v1.0 is an advanced image processing software designed as an optional module for the Olea Sphere 3.0 platform, intended for use by trained breast imaging physicians and MRI technologists. Its primary purpose is to assist in the comprehensive analysis of breast MRI studies, particularly dynamic contrast-enhanced MRI (DCE-MRI), by facilitating visualization, lesion measurement, and reporting. The software comprises two main modules: BreastApp and BreastLoc. BreastApp provides tools for image registration, subtractions, kinetic curve generation, semi-quantitative kinetic maps (e.g., Time to Maximum Enhancement, Wash-in/Washout), semi-automatic lesion segmentation, and measurement of lesion dimensions and volume, along with distances to anatomical landmarks. It also supports multi-modality image viewing (though not primary mammography interpretation) and BI-RADS® compliant reporting and follow-up study comparison. The scientific basis of breastscape v1.0 lies in its ability to process dynamic MR data to quantify contrast uptake characteristics, which are crucial for differentiating and characterizing breast lesions. It employs algorithms for automatic detection of morphological structures and semi-automatic segmentation of suspicious areas, providing objective measurements that can be reviewed and adjusted by the user. The BreastLoc module aids in planning MR-guided breast interventions by calculating needle insertion pathways, depths, and positions within a grid, based on user-defined targets and fiducials. Performance data, including validation testing against predicate and reference devices and a pivotal clinical study, indicate that breastscape v1.0 meets its product specifications and provides information that, when interpreted by a skilled physician, can be used for screening, diagnosis, and interventional planning, with a safety and effectiveness profile comparable to existing technologies. Patient management, however, should not rely solely on its outputs.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the semi-automatic lesion segmentation algorithm in BreastApp handle variations in lesion morphology and contrast uptake patterns across different MRI protocols and scanner vendors?; What is the validated accuracy and reproducibility of the quantitative kinetic parameters (e.g., Time to Maximum Enhancement, Washout) calculated by BreastApp compared to manual analysis or other established software tools?; Can the BreastLoc module integrate with real-time MRI guidance systems, and what is the precision of its needle path calculation when accounting for potential patient movement or breast compression variations during interventional procedures?; How does the software's performance in detecting 'worst kinetics behavior' correlate with histopathological findings for differentiating benign from malignant lesions?; What specific usability features are incorporated to assist users in efficiently adjusting the automatically detected morphological structures and lesion segmentations, and how much user intervention is typically required?